237 related articles for article (PubMed ID: 25469885)
21. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
[TBL] [Abstract][Full Text] [Related]
22. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
[TBL] [Abstract][Full Text] [Related]
23. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
24. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
25. Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.
Carabias P; Espelt MV; Bacigalupo ML; Rojas P; Sarrias L; Rubin A; Saffioti NA; Elola MT; Rossi JP; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
Cell Death Dis; 2022 Jan; 13(1):79. PubMed ID: 35075112
[TBL] [Abstract][Full Text] [Related]
26. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
[TBL] [Abstract][Full Text] [Related]
27. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
28. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.
Liu D; Wu J; Liu M; Yin H; He J; Zhang B
Biochem Biophys Res Commun; 2015 Sep; 464(4):1215-1221. PubMed ID: 26210453
[TBL] [Abstract][Full Text] [Related]
30. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
Chen JS; Su IJ; Leu YW; Young KC; Sun HS
Int J Cancer; 2012 Mar; 130(6):1302-13. PubMed ID: 21469146
[TBL] [Abstract][Full Text] [Related]
31. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM
FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166
[TBL] [Abstract][Full Text] [Related]
32. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
33. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus core protein interacts with Snail and histone deacetylases to promote the metastasis of hepatocellular carcinoma.
Nie D; Shan X; Nie L; Duan Y; Chen Z; Yang Y; Li Z; Tian L; Gao Q; Shan Y; Tang N
Oncogene; 2016 Jul; 35(28):3626-35. PubMed ID: 26549030
[TBL] [Abstract][Full Text] [Related]
35. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
[TBL] [Abstract][Full Text] [Related]
36. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo.
Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H
Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248
[TBL] [Abstract][Full Text] [Related]
37. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Zhu Y; Cheng Y; Guo Y; Chen J; Chen F; Luo R; Li A
Oncotarget; 2016 Feb; 7(5):5327-41. PubMed ID: 26683365
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway.
Lee S; Choi EJ; Cho EJ; Lee YB; Lee JH; Yu SJ; Yoon JH; Kim YJ
Clin Mol Hepatol; 2020 Oct; 26(4):529-539. PubMed ID: 32829570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
